From diet to microbiome therapies: Key insights from the GMFH Summit 2026

19 May 2026

by Manon Oliero, Giovana Martucelli, Andreu Prados

The 14th edition of the Gut Microbiota for Health World Summit brought together leading researchers from around the world to present the latest advances in the field. The meeting reinforced clinical practices that have become increasingly established in recent years and also presented unpublished results on new microbiome-targeted therapies, in line with the summit’s central theme: “Diet and other ways to manipulate the gut microbiome in clinical practice.”

Scientists are starting to elucidate the roots of gastrointestinal symptoms that appear after a meal in people with irritable bowel syndrome. Current research highlights the immune drivers of gut pain, which could offer clues on how to treat IBS.

While the idea that our gut can influence our brain is not new, this is a rapidly growing area of research. Find out more on how gut microbes influence anxiety and stress and why tackling these psychological traits matters for irritable bowel syndrome.

Diets for irritable bowel syndrome: what you need to know

20 Dec 2023

by Andreu Prados, Kate Scarlata

Food is considered the main trigger of digestive symptoms in the vast majority of patients living with IBS. While finding foods that do not prompt gastrointestinal (GI) symptoms has been a challenge for many people with IBS, restrictive diets can come with potential risks. Learn more about diets with evidence in IBS.

Chronic abdominal pain, diarrhea, constipation, and bloating are common gastrointestinal symptoms. While a structural or an organic disease can be suspected because of the symptoms and is often easy to be diagnosed by endoscopy or imaging methods, sometimes gastrointestinal symptoms are not related to any alteration that may be seen through diagnostic techniques, and consequently have been classified under the umbrella of “disorders of gut-brain interaction”.

Bacteria and fungi in the human gut microbiota may contribute to the underlying mechanisms of IBS, which means the latter can be explored as a potential target for IBS. This article explores what is known about the role of the gut microbiome and yeast probiotics in irritable bowel syndrome.

Go to Top